Concepedia

Xuejia Kang

XK

17

Publications

1K

Citations

13

H-Index

2017

Active since

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

Guangzhou University of Chinese Medicine

Auburn University

Nanchang University

Xuejia Kang is an author at Shanghai Institute of Materia Medica specializing in medicine, tumor biology, and cancer research.

ORCID

Top concepts

Publications per year

2017–2024

17

Publications

17

Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

Pengfei Zhao, Yonghui Wang, Xuejia Kang et al. · Chemical Science · 2018 · 243 citations · Full text

Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery

Zening Zheng, Jiaxin Zhang, Jizong Jiang et al. · Journal for ImmunoTherapy of Cancer · 2020 · 132 citations · Full text

Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy

Xuejia Kang, Huiyuan Wang, Huige Peng et al. · Acta Pharmacologica Sinica · 2017 · 108 citations · Full text

, , +9

BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR<sup>T790M</sup> mutation

Weimin Yin, Yuge Zhao, Xuejia Kang et al. · Theranostics · 2020 · 93 citations · Full text

Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR<sup>T790M</sup>‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

Weimin Yin, Xiaolu Yu, Xuejia Kang et al. · Small · 2018 · 78 citations

Rows per page

1–5 of 17